Prof. Shaji Sebastian

Professor Sebastian (Seb) is the lead clinician at the IBD unit in Hull University teaching Hospitals, Hull. He leads an integrated IBD Unit (IBD HULL) of clinical and research staff, which prides itself in personalised care models for IBD patients. IBD Hull has gained recognition as one of the most research-active IBD units in the UK and collaborates in several multicentre national and international IBD studies.

Seb is the chief investigator in 7 ongoing multicentre studies including 2 pan European studies. The current research areas include pharmacogenomics, Transcriptomics in treatment response, novel risk prediction in acute severe colitis, multimodal approach to perianal Crohn`s disease, Inception cohort studies , pharmaco-epidemiology. He has over 300 peer-reviewed publications focussing on IBD (H- index 44 and i10 index to 83 as of 01/07/2022).

He was awarded the NIHR Royal College of Physicians research award for outstanding contribution to research in 2016 and BAME researcher of the year award in 2019. He has been co-author of a number of European Colitis and Crohn`s Organisation (ECCO) guidelines and workshops on various aspects of IBD.

Seb is the current chair of CLINICOM and member of CONFER Task Force committees of European Colitis and Crohn’s Organisation (ECCO), Co-leads the Yorkshire and Humber NIHR LCRN gastroenterology speciality. Nationally, he sits in the British Society of Gastroenterology (BSG) Executive Council, is the current chair of the BSG research committee, current member of BSG IBD Clinical Research Group and BSG International committee, lead of the IBD subgroup of BSG Artificial Intelligence task force, past chair of the adolescent Section of the British Society of Gastroenterology and past member of IBD section Committee. He is also a trustee member on the board of trustees of the national charity GutsUK.